Tickers

CECO — Ticker Eval done nvidia/nemotron-3-ultra-550b-a55b:free

Requested 2026-09-22 10:03:01.196343 UTC · finished 2026-09-22 10:09:18.968491 UTC

1. Composite Trajectory Verdict

Given CECO's project-based industrial model with heavy working capital demands and acquisition-driven growth, all three statements carry weight, but cash flow is the most critical indicator of whether the business model self-funds as management asserts.

Composite Trajectory: Mixed

The annual GAAP earnings trajectory appears strongly improving due to a $63.7 million gain on the Global Pump Solutions divestiture in 2025, but non-GAAP operating income shows steadier growth ($48.1M → $49.4M → $68.4M) with stable margins (8.8%–8.9%). Quarterly GAAP earnings deteriorated sharply in the first half of 2026 (six-month operating loss of $31.3M vs. $79.9M income) driven by $55.7M of Thermon acquisition costs, while non-GAAP operating income rose 85% to $49.9M. Cash generation has deteriorated for three consecutive years (operating cash flow: $44.6M → $24.8M → $5.9M) and turned more negative in H1 2026 (-$32.4M vs. -$19.4M). The balance sheet shifted from modestly deleveraging (debt $218.9M → $212.4M) to highly leveraged (debt $727.7M) after the Thermon acquisition, though liquidity and current ratio improved.

2. Red Flags

  • Earnings–cash divergence: Net income rose from $14.5M (2023) to $53.2M (2025) while operating cash flow fell from $44.6M to $5.9M (10-K 2025-12-31, Consolidated Statements of Cash Flows).
  • Free cash flow turned negative: Operating cash flow ($5.9M) less capex ($11.3M) = -$5.4M in 2025 vs. +$7.4M in 2024 and +$36.2M in 2023 (10-K 2025-12-31, Consolidated Statements of Cash Flows).
  • Operating cash flow increasingly negative quarterly: -$32.4M in H1 2026 vs. -$19.4M in H1 2025 (10-Q 2026-06-30, Condensed Consolidated Statements of Cash Flows).
  • Debt surge: Total debt jumped from $212.4M (Dec 2025) to $727.7M (Jun 2026) to fund Thermon acquisition (10-Q 2026-06-30, Condensed Consolidated Balance Sheets).
  • GAAP/non-GAAP gap widening: 2025 GAAP operating income $105.9M vs. non-GAAP $68.4M (GPS gain); H1 2026 GAAP operating loss ($31.3M) vs. non-GAAP income $49.9M (acquisition costs) (10-K 2025-12-31, MD&A; 10-Q 2026-06-30, MD&A).
  • Gross margin compression: Annual 35.1% → 34.8%; H1 2025 35.7% → H1 2026 30.6% (10-K 2025-12-31, Consolidated Statements of Operations; 10-Q 2026-06-30, Condensed Consolidated Statements of Operations).
  • Recurring "non-recurring" acquisition costs: Acquisition/integration expenses $2.5M (2023), $4.2M (2024), $9.5M (2025), $55.7M (H1 2026) (10-K 2025-12-31, Consolidated Statements of Operations; 10-Q 2026-06-30, Condensed Consolidated Statements of Operations).
  • Goodwill/intangibles balloon: Total assets doubled to $2.0B (Jun 2026) from $894M (Dec 2025) primarily from Thermon purchase accounting (10-Q 2026-06-30, Condensed Consolidated Balance Sheets).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual GAAP operating income surged to $105.9M in 2025 from $35.5M in 2024, but $63.7M of the increase came from the Global Pump Solutions divestiture gain. Non-GAAP operating income grew more steadily: $48.1M (2023) → $49.4M (2024) → $68.4M (2025), with margins flat at 8.8%–8.9%. Revenue grew 38.8% to $774.4M in 2025, driven by Engineered Systems (+41.7%) and acquisitions ($129.4M of sales). In H1 2026, GAAP operating income swung to a $31.3M loss from $79.9M income in H1 2025, due to $55.7M Thermon acquisition costs and absence of the GPS gain; non-GAAP operating income rose 85% to $49.9M (10.2% margin vs. 7.4%). Gross margin compressed from 35.1% to 34.8% annually and from 35.7% to 30.6% in H1, attributed to project mix and acquisition-related costs.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

Operating cash flow has declined for three straight years: $44.6M (2023) → $24.8M (2024) → $5.9M (2025), with the 2025 drop driven by "unfavorable changes in net working capital, particularly increased costs on uncompleted contracts and higher prepaid expenses" (10-K 2025-12-31, MD&A). Free cash flow (operating cash flow minus capex) turned negative in 2025 (-$5.4M). In H1 2026, operating cash flow worsened to -$32.4M from -$19.4M in H1 2025, with the company citing "larger investments in operating assets and liabilities commensurate with growth" (10-Q 2026-06-30, MD&A). Investing cash flow shifted from -$105.3M (2024, acquisition-heavy) to -$1.1M (2025, GPS sale proceeds offsetting Profire acquisition) to -$444.4M in H1 2026 (Thermon acquisition). Financing cash flow swung from +$65.9M (2024) to -$11.6M (2025) to +$509.1M (H1 2026, debt issuance for Thermon).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Annual leverage was stable to slightly improving: total debt $218.9M (2024) → $212.4M (2025); working capital $86.3M → $104.4M; current ratio 1.35 → 1.34; shareholders' equity $251.9M → $323.2M (retained earnings rose from $6.6M to $56.6M). The Thermon acquisition fundamentally altered the balance sheet in H1 2026: total debt jumped to $727.7M (including $235M new term loan), current portion rose to $16.6M from $1.9M, and total assets doubled to $2.0B. Cash increased to $61.1M from $33.1M, working capital to $327.3M, and current ratio to 1.50. The company remained in compliance with all covenants at both dates. Goodwill and intangibles absorb much of the asset increase; the preliminary Thermon purchase price allocation was not finalized as of the Q2 filing.

6. Data Gaps

  • Standalone quarterly results for Q1 2026, Q3 2025, Q4 2025 (only three-month and six-month periods from the Q2 2026 10-Q are available)
  • Full Thermon purchase price allocation and pro forma combined financial statements
  • Segment profit measure definition change in Q4 2025 (prior periods recast but comparability for earlier quarters unclear)
  • Q3 2026 and Q4 2026 results (not yet filed)
  • Organic revenue growth rate for full-year 2024 vs. 2023 (MD&A only provides 2025 vs. 2024)
  • Consolidated Net Leverage Ratio and Consolidated Secured Net Leverage Ratio actual values at each covenant test date (only covenant thresholds disclosed)
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status